Evidence map›Paper›PMID 25293633›Full record

ArticleJournal of agricultural and food chemistry2014

Anti-inflammatory activity of grains of paradise (Aframomum melegueta Schum) extract.

Nebojsa M Ilic, Moul Dey, Alexander A Poulev, Sithes Logendra, Peter E Kuhn, Ilya Raskin

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Journal of agricultural and food chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04381026 nacompletednot on this mapstarted 2017, after this paper: background citation

Study on the Effect of a Nutritional Supplement With Isoflavones on the Symptoms of Climacteric in Healthy Women

TypeinterventionalSponsorNektium Pharma SLRan2017 to 2018Enrolled57ConditionsMenopause, Dietary Supplements, Quality of LifeArmsBotanical dry extracts combination, Placebo
NCT06463145 nacompletednot on this mapstarted 2023, after this paper: background citation

Effects of a Plant Extract Modulating the Endocannabinoid System and Its Anxiolytic Capacity on Elderly People in Situations of Stress or Anxiety

TypeinterventionalSponsorNektium Pharma SLRan2023 to 2023Enrolled37ConditionsSituational AnxietyArmsVanizem, Placebo
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
  9. Assessing the antibacterial potential of 6-gingerol: Combined experimental and computational approaches.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  10. Article
  11. Bioactive Compounds and Signaling Pathways ofLife (Basel, Switzerland) · 2023
    Article
  12. Effect of Ginger on Inflammatory Diseases.Molecules (Basel, Switzerland) · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Enrichment and Purification of Total Ginkgo FlavonoidMolecules (Basel, Switzerland) · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Nebojsa M IlicInstitute of Food Technology, University of Novi Sad , Bulevar cara Lazara 1, 21 000 Novi Sad, Serbia.
Moul Dey
Alexander A Poulev
Sithes Logendra
Peter E Kuhn
Ilya Raskin
Rutgers, The State University of New Jersey · USUniversity of Novi Sad · RS

Funding

Pregnane and Glycosides and Obesity/llya RaskinP50AT002776 · NCCIH · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI RASKIN, ILYA · 2005 to 2019
$24.9M
Building New Pharmaceutical Capabilities in Central AsiaU01TW006674 · FIC · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI RASKIN, ILYA · 2003 to 2008
$4.1M
An alternate therapy for treatment of IBD and prevention of colon cancerK99AT004245 · NCCIH · RUTGERS, THE STATE UNIV OF N.J. · PI DEY, MOUL · 2007 to 2008
$179k
FIC NIH HHS U01 TW006674NCCIH NIH HHS 1-K99 AT004245-01NCCIH NIH HHS 1-P50 AT002776-01
6 · The paper itself

Abstract

The ethanolic extract of grains of paradise (Aframomum melegueta Schum, Zingiberaceae) has been evaluated for inhibitory activity on cyclooxygenase-2 (COX-2) enzyme, in vivo for the anti-inflammatory activity and expression of several pro-inflammatory genes. Bioactivity-guided fractionation showed that the most active COX-2 inhibitory compound in the extract was [6]-paradol. [6]-Shogaol, another compound from the extract, was the most active inhibitory compound in pro-inflammatory gene expression assays. In a rat paw edema model, the whole extract reduced inflammation by 49% at 1000 mg/kg. Major gingerols from the extract [6]-paradol, [6]-gingerol, and [6]-shogaol reduced inflammation by 20, 25 and 38%. respectively when administered individually at a dose of 150 mg/kg. [6]-Shogaol efficacy was at the level of aspirin, used as a positive control. Grains of paradise extract has demonstrated an anti-inflammatory activity, which is in part due to the inhibition of COX-2 enzyme activity and expression of pro-inflammatory genes.

Indexed as

AnimalsAnti-Inflammatory AgentsCatecholsCyclooxygenase 2Cyclooxygenase 2 InhibitorsEdemaFatty AlcoholsHumansMacrophagesMaleMicePlant ExtractsRatsRats, Inbred LECZingiberaceaeAnti-Inflammatory AgentsCatecholsCyclooxygenase 2Cyclooxygenase 2 InhibitorsFatty AlcoholsgingerolPlant ExtractsshogaolAframomum melegueta Schumanti-inflammatoryCOX-2gingerolsgrains of paradisepaw edemaZingiberaceae

Identifiers

PMID25293633
PMCPMC4212708
OpenAlexW1979787441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.